16:55 EDT Soleno Therapeutics up 7% after stock offering, investor purchase agreement
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SLNO:
- Soleno Therapeutics Announces Pricing of Approximately $120 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants
- Soleno Therapeutics Announces Proposed Public Offering of Common Stock and/or Pre-Funded Warrants and a Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants
- Soleno Therapeutics price target raised to $39 from $14 at Oppenheimer
- Soleno Therapeutics price target raised to $35 from $19 at Cantor Fitzgerald
- Soleno Therapeutics up 190% in pre-market after DCCR study data